Celebrating the first annul meeting of MSCO!

For the first time, MSCO brings together oncology professionals and research scientists from Macau, Hong Kong and Guangzhou to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

Novel Direct AMPK Activator Suppresses Non-Small Cell Lung Cancer through Inhibition of Lipid Metabolism

Dr Elaine Lai-Han Leung et al reported that a new AMPK agonist can specifically supress non-small cell lung cancer resistant cells viability by inhibition of lipid metabolism.

Inhibition of KRAS-dependent Lung Cancer Cell Growth by Deltarasin

Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity